Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
14.13
+0.92 (6.96%)
Jul 30, 2026, 10:55 AM CST
SHE:300534 Revenue
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had revenue of 231.59M CNY in the quarter ending March 31, 2026, a decrease of -15.69%. This brings the company's revenue in the last twelve months to 843.87M, down -20.56% year-over-year. In the year 2025, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD had annual revenue of 886.96M, down -14.92%.
Revenue (ttm)
843.87M
Revenue Growth
-20.56%
P/S Ratio
4.75
Revenue / Employee
1.32M
Employees
641
Market Cap
4.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 886.96M | -155.55M | -14.92% |
| Dec 31, 2024 | 1.04B | -37.54M | -3.48% |
| Dec 31, 2023 | 1.08B | 280.37M | 35.06% |
| Jan 1, 2023 | 799.68M | 511.87M | 177.85% |
| Jan 1, 2022 | 287.81M | 32.91M | 12.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Jianmin Pharmaceutical Group | 3.35B |
| Yabao Pharmaceutical Group | 2.20B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Teyi Pharmaceutical Group Co.,Ltd | 839.27M |
| Zhongzhu Healthcare Holding Co.,Ltd | 544.73M |